Aviva’s Tyson Foods TSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.9M Buy
278,198
+1,500
+0.5% +$93.9K 0.02% 464
2026
Q1
$17.7M Buy
276,698
+48,282
+21% +$3M 0.03% 419
2025
Q4
$13.4M Buy
228,416
+11,411
+5% +$627K 0.02% 493
2025
Q3
$11.8M Buy
217,005
+3,467
+2% +$191K 0.02% 504
2025
Q2
$11.9M Buy
213,538
+202,520
+1,838% +$11.6M 0.02% 487
2025
Q1
$703K Sell
11,018
-18,339
-62% -$1.08M ﹤0.01% 642
2024
Q4
$1.69M Buy
29,357
+3,928
+15% +$237K ﹤0.01% 603
2024
Q3
$1.51M Buy
25,429
+1,383
+6% +$84.4K ﹤0.01% 567
2024
Q2
$1.37M Buy
24,046
+13,362
+125% +$781K ﹤0.01% 616
2024
Q1
$627K Sell
10,684
-24
-0.2% -$1.31K ﹤0.01% 822
2023
Q4
$576K Sell
10,708
-3,450
-24% -$168K ﹤0.01% 858
2023
Q3
$715K Buy
14,158
+3,286
+30% +$175K ﹤0.01% 727
2023
Q2
$555K Sell
10,872
-36,122
-77% -$1.97M ﹤0.01% 867
2023
Q1
$2.79M Sell
46,994
-26,699
-36% -$1.64M 0.01% 631
2022
Q4
$4.59M Sell
73,693
-23,295
-24% -$1.52M 0.02% 588
2022
Q3
$6.39M Sell
96,988
-47,678
-33% -$3.77M 0.04% 526
2022
Q2
$12.4M Buy
144,666
+23,200
+19% +$2.08M 0.07% 399
2022
Q1
$10.9M Buy
121,466
+24,669
+25% +$2.25M 0.05% 411
2021
Q4
$8.44M Buy
96,797
+8,998
+10% +$740K 0.04% 444
2021
Q3
$6.93M Sell
87,799
-5,198
-6% -$392K 0.03% 482
2021
Q2
$6.86M Sell
92,997
-2,053
-2% -$159K 0.03% 496
2021
Q1
$7.06M Buy
95,050
+18
+0% +$1.24K 0.03% 432
2020
Q4
$6.12M Buy
95,032
+2,333
+3% +$145K 0.03% 453
2020
Q3
$5.51M Sell
92,699
-2,942
-3% -$181K 0.03% 425
2020
Q2
$5.71M Sell
95,641
-5,542
-5% -$336K 0.04% 398
2020
Q1
$5.86M Buy
101,183
+78
+0.1% +$5.83K 0.04% 368
2019
Q4
$9.21M Sell
101,105
-439
-0.4% -$37.8K 0.06% 300
2019
Q3
$8.75M Sell
101,544
-5,801
-5% -$493K 0.06% 283
2019
Q2
$8.67M Sell
107,345
-2,681
-2% -$207K 0.06% 308
2019
Q1
$7.64M Buy
110,026
+879
+0.8% +$54.4K 0.05% 334
2018
Q4
$5.83M Sell
109,147
-31,431
-22% -$1.85M 0.04% 374
2018
Q3
$8.37M Sell
140,578
-5,995
-4% -$375K 0.05% 373
2018
Q2
$10.1M Buy
146,573
+4,428
+3% +$308K 0.06% 307
2018
Q1
$10.4M Sell
142,145
-13,031
-8% -$995K 0.06% 299
2017
Q4
$12.6M Sell
155,176
-23,530
-13% -$1.8M 0.07% 281
2017
Q3
$12.6M Sell
178,706
-35,447
-17% -$2.27M 0.07% 297
2017
Q2
$13.4M Sell
214,153
-1,320
-0.6% -$80.9K 0.08% 292
2017
Q1
$13.3M Sell
215,473
-15,290
-7% -$963K 0.08% 278
2016
Q4
$14.2M Sell
230,763
-118,239
-34% -$7.77M 0.09% 260
2016
Q3
$26.1M Buy
349,002
+141,649
+68% +$10.4M 0.16% 134
2016
Q2
$13.8M Buy
207,353
+26,037
+14% +$1.69M 0.09% 248
2016
Q1
$12.1M Buy
181,316
+5,668
+3% +$341K 0.09% 248
2015
Q4
$9.37M Buy
175,648
+128
+0.1% +$6.15K 0.07% 303
2015
Q3
$7.57M Sell
175,520
-37,834
-18% -$1.61M 0.06% 343
2015
Q2
$9.1M Sell
213,354
-154,111
-42% -$6.33M 0.06% 325
2015
Q1
$14.1M Buy
367,465
+16,616
+5% +$665K 0.1% 241
2014
Q4
$14.1M Buy
350,849
+4,277
+1% +$173K 0.11% 218
2014
Q3
$13.6M Buy
346,572
+172,253
+99% +$6.59M 0.11% 216
2014
Q2
$6.54M Sell
174,319
-1,022
-0.6% -$40.9K 0.05% 419
2014
Q1
$7.72M Sell
175,341
-15,469
-8% -$586K 0.06% 335
2013
Q4
$6.38M Buy
190,810
+82,870
+77% +$2.53M 0.05% 378
2013
Q3
$3.05M Buy
107,940
+19,248
+22% +$558K 0.03% 582
2013
Q2
$2.28M Buy
+88,692
New +$2.2M 0.02% 578

Other funds holding TSN

Aviva's TSN Position: Q2 2026 in Review

Aviva increased its Tyson Foods (TSN) stake by 0.54% in Q2 2026, buying an estimated $93.9K and bringing the position to 278,198 shares worth $15.9M. The position accounts for 0.02% of the portfolio, ranked #464.

Aviva first reported a position in TSN in Q2 2013 and has held it in 53 quarters since. The position peaked at $26.1M in Q3 2016. 873 funds tracked by Wall St. Rank hold TSN as of Q2 2026.

  • Aviva held 278,198 shares of Tyson Foods worth $15.9M as of Q2 2026.
  • Aviva bought 1,500 Tyson Foods shares in Q2 2026, an estimated $93.9K.
  • Tyson Foods made up 0.02% of Aviva's portfolio in Q2 2026, its #464 holding.
  • Aviva first reported a position in Tyson Foods in Q2 2013 and has held it in 53 quarters since.
  • Aviva's Tyson Foods position peaked at $26.1M in Q3 2016.
  • 873 funds tracked by Wall St. Rank held Tyson Foods as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.